(Q36302245)

English

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

lupus nephritis

11 references

12 March 2019

13 March 2019

17 June 2019

30 June 2019

7 November 2019

12 November 2019

17 November 2019

19 November 2019

1 October 2020

14 October 2020

26 October 2020

1 reference

based on heuristic

inferred from title

14

object named as

John P A Ioannidis

0 references

Ronald van Vollenhoven

27

object named as

Ronald F van Vollenhoven

0 references

Helena Zakharova

object named as

Helena Zakharova

28

0 references

Carlos Vasconcelos

object named as

Carlos Vasconcelos

26

0 references

Maria G Tektonidou

object named as

Maria Tektonidou

2

0 references

object named as

Liz Lightstone

17

0 references

object named as

Andrea Doria

10

0 references

object named as

Martin Aringer

4

0 references

Caroline Gordon

object named as

Caroline Gordon

30

0 references

David A. Isenberg

object named as

David A Isenberg

15

0 references

3

object named as

Zahir Amoura

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

Vladimír Tesař

25

object named as

Vladimir Tesar

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Ricard Cervera i Segura

8

object named as

Ricard Cervera

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Cees G M Kallenberg

16

object named as

Cees G M Kallenberg

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

George K Bertsias

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Ingeborg Bajema

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jo H M Berden

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

John Boletis

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Thomas Dörner

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Franco Ferrario

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jürgen Floege

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Frederic A Houssiau

13

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Stephen D Marks

18

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Alberto Martini

19

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Gabriela Moroni

20

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Irmgard Neumann

21

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Manuel Praga

22

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Matthias Schneider

23

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Argyre Starra

24

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Marion Haubitz

29

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

David Jayne

31

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimitrios T Boumpas

32

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association

33

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

31 July 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 November 2012

12 references

12 March 2019

13 March 2019

17 June 2019

30 June 2019

7 November 2019

12 November 2019

17 November 2019

19 November 2019

29 May 2020

1 October 2020

14 October 2020

26 October 2020

Annals of the Rheumatic Diseases

12 references

Europe PubMed Central

PMC publication ID

13 August 2017

12 March 2019

13 March 2019

17 June 2019

30 June 2019

7 November 2019

12 November 2019

17 November 2019

19 November 2019

1 October 2020

14 October 2020

26 October 2020

71

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1771-1782

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

copyright license

Creative Commons Attribution-NonCommercial

12 references

12 March 2019

13 March 2019

17 June 2019

30 June 2019

7 November 2019

12 November 2019

17 November 2019

19 November 2019

29 May 2020

1 October 2020

14 October 2020

26 October 2020

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Lupus nephritis: role of antinucleosome autoantibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

EULAR recommendations for vaccination in paediatric patients with rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

A Systematic Review and Meta-Analysis of Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus and Lupus Nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Recurrence of lupus nephritis after kidney transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Rituximab therapy in lupus nephritis: current clinical evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Minimal mesangial lupus nephritis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Value of a complete or partial remission in severe lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Hydroxychloroquine in lupus pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Early risk factors for pregnancy loss in lupus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Thrombotic microangiopathy in United States long-term dialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

The classification of glomerulonephritis in systemic lupus erythematosus revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Analysis of lupus activity in end-stage renal disease treated by hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Intravenous immunoglobulin treatment of lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

The prognosis of lupus nephritis in African-Americans: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Cyclophosphamide in lupus nephritis: a controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Why do patients with lupus nephritis die?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Predictors of one year outcome in lupus nephritis: the importance of renal biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

30 September 2017

Isolated pyuria in systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Outcome of renal transplantation in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Recognition of information in renal biopsies of patients with lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Tubulointerstitial renal disease in systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

The Importance of Sample Size in the Interpretation of the Renal Biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Serial assessment of glomerular filtration rate in lupus nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Poor prognosis in end-stage lupus nephritis due to nonautologous vascular access site associated septicemia and lupus flares

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

29 June 2018

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Pharmacokinetics of mycophenolic acid in severe lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Prognostic impact of atypical presentation in pediatric systemic lupus erythematosus: results from a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Peritoneal dialysis and hemodialysis in systemic lupus erythematosus patients: comparison of clinical outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

IgA antiphospholipid antibodies are an independent risk factor for thromboses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Factors affecting kidney-transplant outcome in recipients with lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Systemic lupus erythematosus after renal transplantation: is complement a good marker for graft survival?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Estimating renal function in lupus nephritis: comparison of the Modification of Diet in Renal Disease and Cockcroft Gault equations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy: an open label trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

The long-term prognosis of renal transplantation in patients with lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Low-dose pulse methylprednisolone is an effective therapy for severe SLE flares

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Renal transplantation in systemic lupus erythematosus: a single-center experience with sixty-four cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

22 September 2018

Clinical and prognostic value of serial renal biopsies in lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

21 October 2018

Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

21 October 2018

Immunohistochemical detection of intravascular platelet microthrombi in patients with lupus nephritis and anti-phospholipid antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

5 December 2018

A Randomized Pilot Trial Comparing Cyclosporine and Azathioprine for Maintenance Therapy in Diffuse Lupus Nephritis over Four Years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

5 December 2018

Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465859

5 December 2018

Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine treatment of lupus membranous nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lupus nephritis: clinical and pathological correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertension increases the risk of renal deterioration in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new morphologic index for the evaluation of renal biopsies in lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal replacement therapy in lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glomerular podocytopathy in patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The outcome of renal transplantation among systemic lupus erythematosus patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for hypercreatinemia in patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lupus Atherosclerosis Prevention Study (LAPS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis-a UK-wide study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmapheresis in the treatment of rapidly progressive glomerulonephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal vascular lesions in lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tubular Dysfunction in Proliferative Lupus Nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preemptive kidney transplantation in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The information content from renal biopsy in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal tubular dysfunction in children with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Azathioprine on Renal Histology and Function in Lupus Nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urine protein-to-creatinine ratio in an untimed urine collection is a reliable measure of proteinuria in lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long-term outcome of 93 patients with proliferative lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of treatment on the evolution of renal abnormalities in lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with active systemic lupus erythematosus after endstage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22851469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ANNRHEUMDIS-2012-201940

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36302245&oldid=1624399904"